SPRED1 and melanoma: The six tumors with >50% UV signature had no statistically significant difference in driver genes mutations, but lacked mutations in TP53, SPRED1, SF3B1. There were no other relationships evident between SMGs and primary melanoma anatomic site, primary compared with metastatic/recurrent site or patient ancestry.